Wespac Advisors So Cal, LLC Abb Vie Inc. Transaction History

Wespac Advisors So Cal, LLC

$426 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $66,250 - $79,451	479 Added 1.41%	34,502 $0
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $64,152 - $73,578	-478 Reduced 1.39%	34,023 $4.98 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $84,773 - $107,775	-616 Reduced 1.75%	34,501 $5.28 Million
Q1 2022 May 19, 2022	SELL	$131.98 - $163.75 $3.32 Million - $4.12 Million	-25,152 Reduced 41.73%	35,117 $5.69 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $7.71 Million - $9.76 Million	-71,799 Reduced 54.37%	60,269 $8.26 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $7.35 Million - $9.3 Million	68,442 Added 107.57%	132,068 $6.57 Million
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $2.44 Million - $2.77 Million	-22,941 Reduced 26.5%	63,626 $6.97 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $249,347 - $277,787	2,370 Added 2.81%	86,567 $9.75 Million
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $1.22 Million - $1.35 Million	-11,973 Reduced 12.45%	84,197 $9.11 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $2.25 Million - $3.04 Million	28,010 Added 41.09%	96,170 $10.3 Million
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $4.79 Million - $5.62 Million	55,740 Added 448.79%	68,160 $5.98 Million
Q2 2020 Jul 17, 2020	SELL	$73.37 - $98.18 $89,878 - $120,270	-1,225 Reduced 8.98%	12,420 $1.2 Million
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $129,000 - $195,580	-2,000 Reduced 12.78%	13,645 $1.14 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $51,933 - $64,980	-720 Reduced 4.4%	15,645 $1.39 Million
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $14,170 - $17,037	225 Added 1.39%	16,365 $1.24 Million
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $383,950 - $490,779	5,844 Added 56.76%	16,140 $1.17 Million
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $63,640 - $74,901	-825 Reduced 7.42%	10,296 $829,000
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $87,814 - $108,299	-1,128 Reduced 9.21%	11,121 $1.03 Million
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $68,905 - $76,601	775 Added 6.75%	12,249 $1.16 Million
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $26,125 - $30,912	-291 Reduced 2.47%	11,474 $1.06 Million
Q1 2018 Apr 16, 2018	SELL	$92.01 - $123.21 $1.05 Million - $1.4 Million	-11,385 Reduced 49.18%	11,765 $1.11 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $1.03 Million - $1.12 Million	11,450 Added 97.86%	23,150 $2.15 Million
Q3 2017 Nov 03, 2017	SELL	$69.85 - $89.22 $29,686 - $37,918	-425 Reduced 3.51%	11,700 $1.04 Million
Q2 2017 Aug 11, 2017	BUY	N/A	12,125	12,125 $879,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.

Account